Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen
Conditions: Cirrhosis, Liver; Vaccination Failure; HBV; Vaccine Reaction Interventions: Drug: IMIQUIMOD cream; Biological: HEPATITIS B SURFACE ANTIGEN Sponsor: Central Hospital, Nancy, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2021 Category: Research Source Type: clinical trials